Senior Computational Biologist - Translational and Clinical Biomarkers jobs in United States
cer-icon
Apply on Employer Site
company-logo

Recursion · 2 weeks ago

Senior Computational Biologist - Translational and Clinical Biomarkers

Recursion is a clinical stage TechBio company focused on radically improving lives through advanced biology decoding. The Senior Computational Biologist will lead computational efforts in drug development, evaluating therapeutic hypotheses and collaborating with cross-functional teams to advance drug candidates through clinical trials.

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Evaluate the molecular evidence for predictive and PD biomarker hypotheses in translational models and clinical samples (DNA, RNA, ctDNA, and novel exploratory modalities)
Pilot novel methods for patient stratification and indication selection or expansion
Deliver biological insights on therapeutic candidates and disease biology from the analysis of high dimensional (phenomics, transcriptomics, patient-derived) datasets
Present data analysis to decision makers and stakeholders in a clear and compelling way that drives toward getting medicines to patients
Industrialize analysis approaches to not only solve for the current project, but also accelerate future projects and scale the impact that we can have
Collaborate cross-functionally with Recursion’s data science, platform, ML and clinical teams to further advance Recursion’s ability to leverage our own clinical data in meta-analysis, hypothesis generation, and reverse translation

Qualification

Computational BiologyHigh Dimensional Data AnalysisMachine LearningPhD in Relevant FieldData VisualizationPatient Biomarker DataDrug Discovery ExperienceStakeholder ManagementCross-Functional CollaborationCommunication Skills

Required

PhD in a relevant field (computational biology, systems biology, bioinformatics, cancer biology, immuno-oncology, etc.) with a very strong computational focus and 3+ years of experience in biotech or pharma industry OR MS in a relevant field and 5+ years of experience in biotech or pharma industry solving fundamental problems in oncology or drug discovery
Experience with high dimensional patient biomarker data from clinical trials in oncology
Strong understanding of patient genetics and druggability of disease relevant pathways
Experience applying computational methods (including probabilistic, statistical, and/or machine learning techniques) to analyze and integrate complex biological and/or human clinical data in a high level programming language such as Python or R
Deep expertise in the analysis and data integration of two or more ‘omics data modalities (phenomics, transcriptomics, proteomics, genomics) including experience with matched clinical and molecular patient data
Exceptional data visualization skills
Excellent cross-functional communication skills, including an ability to explain complex scientific concepts to a variety of audiences using a combination of plots, documents, and presentations

Preferred

Experience with late stage drug discovery and IND submission
Experience collaborating cross-functionally with biometrics, statistical sciences and clinical pharmacology departments

Benefits

Annual bonus
Equity compensation
Comprehensive benefits package

Company

Recursion

company-logo
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.

H1B Sponsorship

Recursion has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)

Funding

Current Stage
Public Company
Total Funding
$865.38M
Key Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M

Leadership Team

leader-logo
Chris Gibson
Co-Founder and CEO
linkedin
leader-logo
Ben Mabey
Chief Technology Officer
linkedin

Recent News

Company data provided by crunchbase